AI Rules: New Orders, Risks, and Health Care

On July 23, 2025, the administration that assumed office in January 2025 released a bundle of executive orders and policy papers about artificial intelligence. The documents cover many areas of tech and set the stage for a new direction in U.S. strategy. They were released with little fanfare but quickly drew attention from analysts and industry watchers.

One of the orders tells federal agencies to stop buying or using AI systems that push diversity, equity, and inclusion goals. The language avoids the term "woke AI" but makes the stance clear. A separate 28‑page action plan follows, declaring that the United States is locked in a global contest for AI supremacy. It calls for more research, faster innovation, and less regulation, especially in health care, where the plan says rules are holding progress back.

The plan’s authors argue that loosening rules will let new AI tools reach patients sooner, potentially improving diagnosis and treatment. They also warn that without careful oversight, new health products might not reflect the varied populations they serve. The reduced pre‑market checks could erode confidence among doctors and patients, raising questions about safety and fairness.

Together, these moves promise both upside and downside for health‑related AI. On one hand, fewer barriers could spark breakthroughs and speed up real‑world use. On the other, the focus on competition over inclusion may leave gaps in representation, and the lighter review process might weaken trust in the technology. Observers are now debating how to balance rapid progress with ethical safeguards.